Bingfeng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bingfeng Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Hua-Guo Xu
Department of Laboratory Medicine, the First Affiliated Hospital with, Nanjing Medical University, Nanjing, China
3 shared publications - Jian Xu
Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
2 shared publications - Yuan Mu
Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
2 shared publications Erfu Xie
Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
1 shared publication- Hong Wang
The First Affiliated Hospital of Nanjing Medical University
1 shared publication Hui Zhang
Department of Laboratory Medicine, Liyang People's Hospital, Liyang, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 657
IgM–C4d Complex Causes the Inaccurate Measurement of Serum Uric Acid Levels via the Uricase Method
Accurate measurement of serum uric acid (UA) is critical for disease assessment and therapeutic monitoring; however, numerous factors can compromise the accuracy of UA detection. This study describes a novel circulating immunoglobulin M (IgM)-involved protein complex that interferes with the uricase method and reduces serum UA measurement accuracy. A total of 24 serum samples were collected from 18 patients, and complete clinical information and laboratory data were obtained. Samples were divided into three groups according to their UA reaction curves. Optical density values were extracted to analyze differential insoluble properties, serum viscosity was measured, coimmunoprecipitation was performed for IgM complex detection, and three additional clinical methodologies were used for UA measurement and comparison. All samples exhibiting unique reaction curves showed simultaneous elevations in IgM and complement component 4 (C4) levels. Circulating IgM formed a protein complex with C4d without significantly increasing serum viscosity. The insolubility of the IgM–C4d complex was attributable to the particular alkaline component of the uricase reagent. Inaccurate UA measurements could only be corrected by mass spectrometry. This study represents the first report of the circulating IgM–C4d protein complex. Given that serum UA serves as a crucial therapeutic indicator for specific patient populations, mass spectrometry is the preferred analytical method for accurate UA quantification in these individuals.
- 25 June 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 657
Open AccessIgM–C4d Complex Causes the Inaccurate Measurement of Serum Uric Acid Levels via the Uricase Method
Accurate measurement of serum uric acid (UA) is critical for disease assessment and therapeutic monitoring; however, numerous factors can compromise the accuracy of UA detection. This study describes a novel circulating immunoglobulin M (IgM)-involved protein complex that interferes with the uricase method and reduces serum UA measurement accuracy. A total of 24 serum samples were collected from 18 patients, and complete clinical information and laboratory data were obtained. Samples were divided into three groups according to their UA reaction curves. Optical density values were extracted to analyze differential insoluble properties, serum viscosity was measured, coimmunoprecipitation was performed for IgM complex detection, and three additional clinical methodologies were used for UA measurement and comparison. All samples exhibiting unique reaction curves showed simultaneous elevations in IgM and complement component 4 (C4) levels. Circulating IgM formed a protein complex with C4d without significantly increasing serum viscosity. The insolubility of the IgM–C4d complex was attributable to the particular alkaline component of the uricase reagent. Inaccurate UA measurements could only be corrected by mass spectrometry. This study represents the first report of the circulating IgM–C4d protein complex. Given that serum UA serves as a crucial therapeutic indicator for specific patient populations, mass spectrometry is the preferred analytical method for accurate UA quantification in these individuals.
- 2 February 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 541, 117242
Effects of centrifugation prior to pneumatic tube system transport on routine biochemical and immunological tests of susceptibility to hemolysis
- 2 February 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 541, 117242
Effects of centrifugation prior to pneumatic tube system transport on routine biochemical and immunological tests of susceptibility to hemolysis
- Open Access
- 2 August 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 33 (9) , e22991
Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement
Background: Internal quality control (IQC) in clinical laboratories is carried out to monitor analytical stability. Usually, the satisfactory results of the IQC ensure the acceptability of the examination results. Here, we reported that patients' creatinine results are unreliable, although the internal quality control is satisfactory.Methods: Creatinine levels were analyzed from two quality control materials and twenty patients' specimens using two different lots of reagents. Lot‐to‐lot comparison was performed. The daily median values of serum creatinine levels of patients were calculated from the test results recorded in our laboratory information system.Results: Although IQC was consistent, serum creatinine concentrations were higher using lot B (median: 153 μmol/L; interquartile range: 122‐522 μmol/L) than using lot A (median: 133 μmol/L; interquartile range: 76‐508 μmol/L) for 20 patients (P = .001). The Deming linear regression showed a best fit of y = 0.9394 × x + 45.66. R2 = .8919, and mean percentage difference between two lots was 34%. The new lot was considered unacceptable. Likewise, the median serum creatinine level from the 360 patients using lot B was 102 μmol/L, which was significantly higher than the daily medians of patients using lot A (median: 66 μmol/L; range: 61‐70 μmol/L) in the previous month.Conclusion: The variations in creatinine concentrations proved to be due to different lots of reagents. However, IQC materials tested using both lots of reagent exhibited minimal variation. Therefore, IQC alone is insufficient for assessing laboratory analytical results. This finding prompts us to be vigilant in potential pitfall of interpreting test results based on satisfactory IQC alone.
- 2 August 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 33 (9) , e22991
Open AccessFailure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement
Background: Internal quality control (IQC) in clinical laboratories is carried out to monitor analytical stability. Usually, the satisfactory results of the IQC ensure the acceptability of the examination results. Here, we reported that patients' creatinine results are unreliable, although the internal quality control is satisfactory.Methods: Creatinine levels were analyzed from two quality control materials and twenty patients' specimens using two different lots of reagents. Lot‐to‐lot comparison was performed. The daily median values of serum creatinine levels of patients were calculated from the test results recorded in our laboratory information system.Results: Although IQC was consistent, serum creatinine concentrations were higher using lot B (median: 153 μmol/L; interquartile range: 122‐522 μmol/L) than using lot A (median: 133 μmol/L; interquartile range: 76‐508 μmol/L) for 20 patients (P = .001). The Deming linear regression showed a best fit of y = 0.9394 × x + 45.66. R2 = .8919, and mean percentage difference between two lots was 34%. The new lot was considered unacceptable. Likewise, the median serum creatinine level from the 360 patients using lot B was 102 μmol/L, which was significantly higher than the daily medians of patients using lot A (median: 66 μmol/L; range: 61‐70 μmol/L) in the previous month.Conclusion: The variations in creatinine concentrations proved to be due to different lots of reagents. However, IQC materials tested using both lots of reagent exhibited minimal variation. Therefore, IQC alone is insufficient for assessing laboratory analytical results. This finding prompts us to be vigilant in potential pitfall of interpreting test results based on satisfactory IQC alone.